Opelconazole
Term · Oncology and biomedicine · MLC-T-ONC-015680
A synthetic triazole antifungal agent, with activity against a variety of pathogenic fungi that can potentially be used against invasive pulmonary aspergillosis. Upon inhalation by nebulizer, opelconazole is delivered in high concentrations to the lungs and resides in the lung tissues for a long period of time with minimal systemic exposure. Opelconazole selectively binds to and inhibits the CYP450-dependent 14-alpha-sterol demethylase in fungi, thereby preventing the production of ergosterol, which is an essential constituent of the fungal cell membrane. This results in fungal cell lysis and inhibits fungal infection in the lungs.
| Identifier | MLC-T-ONC-015680 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | antifungal PC945; inhaled antifungal PC945; triazole antifungal PC945 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015680",
"term": "Opelconazole",
"field": "Oncology and biomedicine",
"definition": "A synthetic triazole antifungal agent, with activity against a variety of pathogenic fungi that can potentially be used against invasive pulmonary aspergillosis. Upon inhalation by nebulizer, opelconazole is delivered in high concentrations to the lungs and resides in the lung tissues for a long period of time with minimal systemic exposure. Opelconazole selectively binds to and inhibits the CYP450-dependent 14-alpha-sterol demethylase in fungi, thereby preventing the production of ergosterol, which is an essential constituent of the fungal cell membrane. This results in fungal cell lysis and inhibits fungal infection in the lungs.",
"synonyms": [
"antifungal PC945",
"inhaled antifungal PC945",
"triazole antifungal PC945"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/opelconazole/"
}
Record 12,261 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.